Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Radiology and Oncology
Volume 49 (2015): Numero 4 (December 2015)
Accesso libero
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
Norimitsu Kasahara
Norimitsu Kasahara
,
Hisao Imai
Hisao Imai
,
Kyoichi Kaira
Kyoichi Kaira
,
Keita Mori
Keita Mori
,
Kazushige Wakuda
Kazushige Wakuda
,
Akira Ono
Akira Ono
,
Tetsuhiko Taira
Tetsuhiko Taira
,
Hirotsugu Kenmotsu
Hirotsugu Kenmotsu
,
Hideyuki Harada
Hideyuki Harada
,
Tateaki Naito
Tateaki Naito
,
Haruyasu Murakami
Haruyasu Murakami
,
Masahiro Endo
Masahiro Endo
,
Takashi Nakajima
Takashi Nakajima
,
Masanobu Yamada
Masanobu Yamada
e
Toshiaki Takahashi
Toshiaki Takahashi
| 27 nov 2015
Radiology and Oncology
Volume 49 (2015): Numero 4 (December 2015)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
27 nov 2015
Pagine:
409 - 415
Ricevuto:
31 gen 2015
Accettato:
06 lug 2015
DOI:
https://doi.org/10.1515/raon-2015-0037
Parole chiave
chemoradiotherapy
,
limited-stage disease small cell lung cancer
,
overall survival
,
post-progression survival
,
progression-free survival
© 2015 Norimitsu Kasahara et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Norimitsu Kasahara
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Hisao Imai
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Kyoichi Kaira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Japan
Keita Mori
Clinical Trial Coordination Office, Shizuoka Cancer Center, Japan
Kazushige Wakuda
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Akira Ono
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Tetsuhiko Taira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hirotsugu Kenmotsu
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hideyuki Harada
Division of Radiation Oncology, Shizuoka Cancer Center, Japan
Tateaki Naito
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Haruyasu Murakami
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Masahiro Endo
Division of Diagnostic Radiology, Shizuoka Cancer Center, Japan
Takashi Nakajima
Division of Diagnostic Pathology, Shizuoka Cancer Center, Japan
Masanobu Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Toshiaki Takahashi
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan